Knowledge empowers us to navigate through life’s choices and decisions. With solutions that provide real-time, definitive results; at Sapphiros we work together to help global communities act on these insights with confidence.
Family of Companies
Sapphiros AI Bio computational biology company developing high-performance computing, machine learning, and artificial intelligence solutions for biochemistry, cell biology, and diagnostics.
Sapphiros Laboratories is a leading provider of genetic and COVID-19 testing.
Biocrucible aims to develop proprietary molecular detection technologies deploying ultra-rapid isothermal nucleic acid amplification that enable near patient and at-home testing for infectious disease or generic indications.
We believe that progress requires leadership, courage and conviction. Our platform supports the next generation of diagnostics, aiming to bridge the gap between present and future.
Who We Are
We are a team of seasoned healthcare executives with a proven track record of execution and years of experience as entrepreneurs, operators, and investors. We are backed by leading global investment firm KKR.
What We Do
We partner with and support talented entrepreneurs that have the vision and passion to bring transformative new diagnostic technologies to the world.
How We Do It
We invest in growth stage diagnostic companies and empower them with the full strength of our collective resources, capital, and expertise.
We Innovate Together
We work as a team to deliver extraordinary and disruptive innovation & technology that changes healthcare
We Care for Each Other
We care: for each other, our customers and our partners
We Deliver on our commitments
Individually and as a team we are accountable to deliver on our commitments and always focus on creating value for our customers, investors and partners